References
- Reichert JM. Which are the antibodies to watch in 2013?. MAbs 2013; 5:1 - 4; http://dx.doi.org/10.4161/mabs.22976; PMID: 23254906
- Reichert JM. Which are the antibodies to watch in 2012?. MAbs 2012; 4:1 - 3; http://dx.doi.org/10.4161/mabs.4.1.18719; PMID: 22327425
- Reichert JM. Antibody-based therapeutics to watch in 2011. MAbs 2011; 3:76 - 99; http://dx.doi.org/10.4161/mabs.3.1.13895; PMID: 21051951
- Reichert JM. Antibodies to watch in 2010. MAbs 2010; 2:84 - 100; http://dx.doi.org/10.4161/mabs.2.1.10677; PMID: 20065640
- Mullard A. Maturing antibody-drug conjugate pipeline hits 30. Nat Rev Drug Discov 2013; 12:329 - 32; http://dx.doi.org/10.1038/nrd4009; PMID: 23629491